Junli Capital

Junli Capital is a Beijing, China-based investment firm specializing in private equity and venture capital, focusing on high-growth companies across technology, healthcare, and consumer sectors. The firm manages over 10 billion RMB (approximately $1.4 billion USD) in assets under management and employs around 50-100 professionals. In 2024, Junli Capital closed a 5 billion RMB fund dedicated to AI and biotech investments, further expanding its portfolio which includes stakes in companies like Xiaohongshu (Little Red Book) and Meituan affiliates. Its capital is sourced from institutional investors, including China sovereign funds and family offices, and the firm has recently partnered with international VCs for cross-border deals. Junli Capital was founded in 2015 by Managing Partner Li Jun. Its business model centers on raises funds through limited partner investments from institutional investors and high-net-worth individuals to deploy into private equity and venture deals, earning management fees and carried interest.